Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ServiceNow Inc (NOW) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance

ServiceNow IncTrade
SELLAS Life Sciences Group Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

ServiceNow Inc vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? ServiceNow Inc trades at $139.71 (market cap $144.48B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.64 (market cap $2.27B). The key difference: ServiceNow Inc is far larger — about 63.6× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, ServiceNow Inc nearer its low. Which is the better fit depends on your goals.

NOWSLS
Market Cap
$144.48B$2.27B
Volume
11,801,6994,179,659
Sector
TechnologyHealth
52-Week High
$189.26$15.46
52-Week Low
$83.00$1.39
Typical Hold Time
54 Days—
Enterprise Value
$148.27B$2.14B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ServiceNow Inc

ServiceNow (NOW) trades at $137.87, down slightly by 0.07% on the day. The stock shows strong fundamental momentum with revenue growing from $7.2B in 2022 to $13.3B in 2025 and consistent earnings beats in recent quarters. Technical indicators are bullish with the price above key moving averages, while analyst sentiment remains overwhelmingly positive with 87% buy ratings and a $146.04 consensus target. The company's AI business has surpassed $1 billion in annual contract value, driving investor optimism.

ServiceNow presents a compelling growth story with robust AI adoption and expanding enterprise workflow solutions. The primary investment opportunity lies in the company's leadership position in enterprise AI and strong subscription revenue growth. Key risks include premium valuation multiples (P/E of 87.34), increasing competition in cloud software, and potential margin pressure as AI investments scale. The stock offers upside to analyst targets but requires monitoring of execution against ambitious growth projections.

SELLAS Life Sciences Group Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NOW
43% Buy57% Sell
Avg holding period · 54 Days
SLS

No sentiment data available yet.

Top news

Latest headlines on both assets

About ServiceNow Inc

ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management (ITSM), expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service (PaaS).

Read more on NOW →

About SELLAS Life Sciences Group Inc. Common Stock

SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.

Read more on SLS →